Isabelle De Cremoux is the CEO and President of French VC fund Seventure Partners, famous for having opened Health for Life Capital, a €160M fund dedicated to the Microbiome.
Having previously worked in the business development team of Pfizer as well as Fournier/Abbott, Isabelle created the lifesciences department when joining Seventure, which she manages as CEO for over 3 years now.
Seventure is an active investor in Europe, managing about €600M. In addition to these activities, it has successfully launched 2 institutional funds at the end of 2013, one of which was the Health for Life Capital fund, which has now amassed around €160M from partners like Novartis and Danone.
Now 3 months later, I was curious to know where they stand…
So Isabelle, could you provide me with an update on the first 3 months of the fund?
Everything has been running smoothly since the opening. We have done 8 deals so far,